(Q51566677)

7 April 2018

title

Insulin sensitivity, insulin action, and fibrinolysis activity in nondiabetic and diabetic obese subjects. (English)

1 reference

7 April 2018

0 references

1 reference

5

Lalau JD

1 reference

7 April 2018

author name string

Fendri S

1

1 reference

7 April 2018

Roussel B

2

1 reference

7 April 2018

Lormeau B

3

1 reference

7 April 2018

Tribout B

4

1 reference

7 April 2018

publication date

1 November 1998

1 reference

7 April 2018

published in

Metabolism

1 reference

7 April 2018

volume

47

1 reference

7 April 2018

issue

11

1 reference

7 April 2018

page(s)

1372-1375

1 reference

7 April 2018

Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990307-9

Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990307-9

Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990307-9

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990307-9

Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990307-9

Insulin treatment reverses the insulin resistance of type II diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990307-9

Insulin therapy in type 2 diabetic subjects suppresses plasminogen activator inhibitor (PAI-1) activity and proinsulin-like molecules independently of glycaemic control.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990307-9

Hyperinsulinemia and hypofibrinolysis: effects of short-term optimized glycemic control with continuous insulin infusion in type II diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990307-9

Methods for the evaluation of human fibrinolysis; studies with two combined technics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990307-9

Endogenous tissue-type plasminogen activator and risk of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990307-9

Proinsulin, intact insulin, and fibrinolytic variables and fibrinogen in healthy subjects. A population study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990307-9

Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990307-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0026-0495(98)90307-9

1 reference

7 April 2018

1 reference

7 April 2018